ATE342061T1 - Verwendung eines nicht-neutralisierenden antikörpers spezifisch für die beta-untereinheit von luteinisierendem hormon zur erhöhung der fertilität - Google Patents

Verwendung eines nicht-neutralisierenden antikörpers spezifisch für die beta-untereinheit von luteinisierendem hormon zur erhöhung der fertilität

Info

Publication number
ATE342061T1
ATE342061T1 AT95911043T AT95911043T ATE342061T1 AT E342061 T1 ATE342061 T1 AT E342061T1 AT 95911043 T AT95911043 T AT 95911043T AT 95911043 T AT95911043 T AT 95911043T AT E342061 T1 ATE342061 T1 AT E342061T1
Authority
AT
Austria
Prior art keywords
present
stimulating
luteinizing hormone
fertility
activity
Prior art date
Application number
AT95911043T
Other languages
English (en)
Inventor
William R Moyle
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE342061T1 publication Critical patent/ATE342061T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Control Of Eletrric Generators (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95911043T 1994-02-18 1995-02-17 Verwendung eines nicht-neutralisierenden antikörpers spezifisch für die beta-untereinheit von luteinisierendem hormon zur erhöhung der fertilität ATE342061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19938294A 1994-02-18 1994-02-18

Publications (1)

Publication Number Publication Date
ATE342061T1 true ATE342061T1 (de) 2006-11-15

Family

ID=22737277

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97122148T ATE314392T1 (de) 1994-02-18 1995-02-17 Einzelketten-gonadotropin
AT95911043T ATE342061T1 (de) 1994-02-18 1995-02-17 Verwendung eines nicht-neutralisierenden antikörpers spezifisch für die beta-untereinheit von luteinisierendem hormon zur erhöhung der fertilität

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97122148T ATE314392T1 (de) 1994-02-18 1995-02-17 Einzelketten-gonadotropin

Country Status (11)

Country Link
US (2) US7001597B1 (de)
EP (3) EP0751782B1 (de)
JP (3) JPH09509418A (de)
AT (2) ATE314392T1 (de)
AU (1) AU695111B2 (de)
CA (1) CA2183564C (de)
DE (2) DE69534723T2 (de)
DK (1) DK0751782T3 (de)
ES (2) ES2273335T3 (de)
PT (1) PT751782E (de)
WO (1) WO1995022340A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250975A1 (en) * 1996-04-15 1997-10-23 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
AU4964197A (en) * 1996-11-12 1998-06-03 Teikoku Hormone Mfg. Co., Ltd. Recombinant single-stranded equine chorionic gonadotropin
ZA987497B (en) * 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6635256B1 (en) * 1998-10-19 2003-10-21 Washington University Glycoprotein hormone compositions comprising two β subunits and methods of use thereof
US6103501A (en) * 1997-11-17 2000-08-15 Washington University Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
US5981249A (en) * 1998-02-05 1999-11-09 Spectral Diagnostics, Inc. Single-chain polypeptides comprising creatine kinase M and creatine kinase B
WO2000017360A1 (en) * 1998-09-22 2000-03-30 University Of Maryland, Baltimore Cystine knot growth factor mutants
DE19910394A1 (de) * 1999-03-03 2000-09-07 Schering Ag Substanzen für die Fertilitätskontrolle
US6342411B1 (en) * 1999-09-03 2002-01-29 Motorola Inc. Electronic component and method for manufacture
KR20010077538A (ko) * 2000-02-03 2001-08-20 김강권 단일체인 융모성성선자극호르몬 및 그 제조방법
WO2001081406A2 (en) * 2000-04-25 2001-11-01 Washington University Single-chain fertility hormones with variable lh activity
JP2001333772A (ja) 2000-04-25 2001-12-04 Washington Univ 可変性の活性を有する単鎖稔性ホルモン
US6987172B2 (en) 2001-03-05 2006-01-17 Washington University In St. Louis Multifunctional single chain glycoprotein hormones comprising three or more β subunits
PL1518863T3 (pl) * 2003-09-26 2011-05-31 Inst Nat De La Rech Agronomique Inra Przeciwciała modulujące aktywność końskiej gonadotropiny kosmówkowej
EP3765841A4 (de) * 2018-03-16 2022-06-08 Quest Diagnostics Investments LLC Massenspektrometrische bestimmung von testosteron in multiplexierten patientenproben
BR102019004147A2 (pt) 2019-02-28 2020-10-06 Ouro Fino Saude Animal Participacoes S.A. Gonadotrofina coriônica equina recombinante (recg) biologicamente ativa e processo para obtenção da mesma, composição veterinária e uso

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US5284778A (en) * 1985-08-12 1994-02-08 The Trustees Of Columbia University In The City Of New York Sensitive bioassay using monoclonal antibodies which bind to hormone-receptor complexes
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
DE3856559T2 (de) * 1987-05-21 2004-04-29 Micromet Ag Multifunktionelle Proteine mit vorbestimmter Zielsetzung
WO1991016922A1 (en) * 1990-05-08 1991-11-14 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
ATE193540T1 (de) * 1991-06-18 2000-06-15 Univ New Jersey Med Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
CN1157408C (zh) * 1994-08-12 2004-07-14 华盛顿大学 以糖蛋白激素四成员家族的单链形式存在的糖蛋白激素活性的促效剂或拮抗剂

Also Published As

Publication number Publication date
CA2183564A1 (en) 1995-08-24
DE69534723D1 (de) 2006-02-02
EP0751782A1 (de) 1997-01-08
PT751782E (pt) 2007-01-31
JPH11263799A (ja) 1999-09-28
US20070253955A1 (en) 2007-11-01
EP1849802A2 (de) 2007-10-31
JPH09509418A (ja) 1997-09-22
EP0839831A2 (de) 1998-05-06
DE69535260D1 (de) 2006-11-23
ES2251731T3 (es) 2006-05-01
DE69534723T2 (de) 2006-08-31
ES2273335T3 (es) 2007-05-01
DE69535260T2 (de) 2007-08-09
AU1878795A (en) 1995-09-04
EP0751782A4 (de) 2000-09-27
US7001597B1 (en) 2006-02-21
ATE314392T1 (de) 2006-01-15
EP0839831A3 (de) 1999-09-29
AU695111B2 (en) 1998-08-06
DK0751782T3 (da) 2007-01-29
WO1995022340A1 (en) 1995-08-24
EP0751782B1 (de) 2006-10-11
JP2002060347A (ja) 2002-02-26
EP0839831B1 (de) 2005-12-28
CA2183564C (en) 2010-07-13

Similar Documents

Publication Publication Date Title
ATE342061T1 (de) Verwendung eines nicht-neutralisierenden antikörpers spezifisch für die beta-untereinheit von luteinisierendem hormon zur erhöhung der fertilität
Flack et al. Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line
Beebe et al. Lentropin, a protein that controls lens fiber formation, is related functionally and immunologically to the insulin-like growth factors.
Oxberry et al. An autoradiographic study of the binding of 125I-labeled follicle-stimulating hormone, human chorionic gonadotropin and prolactin to the hamster ovary throughout the estrous cycle
CA2053864A1 (en) Modified forms of reproductive hormones
NZ223154A (en) Composition and method for producing superovulation in cattle comprising fsh and lh
DE3884776D1 (de) Durch "site-directed" Mutagenese modifzierte Glukoprotein-Hormone und Verfahren zu deren Verwendung.
US20020165366A1 (en) Method for purifying FSH
Kardami et al. Selected muscle and nerve extracts contain an activity which stimulates myoblast proliferation and which is distinct from transferrin
Mattioli et al. Nerve growth factor production in sheep antral follicles☆
Jablonka-Shariff et al. Expression and bioactivity of a single chain recombinant equine luteinizing hormone (reLH)
ATE115409T1 (de) Glykoprotein-hormonrezeptor-moleküle.
Ulloa-Aguirre et al. Effects of gonadotrophin-releasing hormone, recombinant human activin-A and sex steroid hormones upon the follicle-stimulating isohormones secreted by rat anterior pituitary cells in culture
Hakola et al. Recombinant forms of rat and human luteinizing hormone and follicle-stimulating hormone; comparison of functions in vitro and in vivo
Xing et al. Efficient preparation of glycoprotein hormones lacking an α-subunit oligosaccharide
Chaudhary et al. Purification of bubaline luteinizing hormone by gel filtration chromatography in the presence of blue dextran
ATE491726T1 (de) Antikörper modulierende die biologische aktivität von pferd-choriongonadotropin
Carter et al. Comparative aspects of placental evolution: a workshop report
DE4000327A1 (de) Arzneimittel zur verbesserung der ovarreaktion und der eizell- und embryonen- produktion bei haussaeugetieren
Matteri et al. Biochemical and biological properties of urinary follicle‐stimulating hormone (FSH) from the rhesus monkey (Macaca mulatta)
Chaudhary et al. Caprine (Capra hircus) luteinizing hormone: purification and chromatographic investigation of its different isoforms
Chand et al. A reference preparation of buffalo pituitary follicle stimulating hormone using lectin affinity chromatography
Stone et al. Between-lot variability in chromatographic and biochemical properties of hMG
Quesnel et al. Solubilization and purification of the gonadotropin (GTH II) receptor from rainbow trout (Oncorhynchus mykiss) ovaries
Rennels et al. The Anterior Pituitary Gland—Its Cells and Hormones

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0751782

Country of ref document: EP

EEFA Change of the company name